Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Roche Holding AG Akt 1.04% CHF232.83B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback